- The Washington Times - Tuesday, December 14, 2004

The nose is the newest clue to Alzheimer’s disease. A simple scent test could determine whether a case of mild, short-term memory loss will develop into the progressive neurological disorder.

Specific scents are the key.

Strawberry, smoke, soap, menthol, clove, pineapple, natural gas, lilac, lemon and leather: People with mild cognitive impairment who cannot identify these scents will develop Alzheimer’s disease, according to research from the American College of Neuropsychopharmacology.

Based at Vanderbilt University, the 700-member research group released the findings yesterday during an annual meeting.

The “10-smell test,” which takes only a few minutes, is as accurate a predictor for the disease as a more complex memory test or an expensive magnetic resonance imaging that measures brain volume, researchers say.

“Early diagnosis of Alzheimer’s disease is critical for patients and their families to receive the most beneficial treatment and medications,” said study author Dr. D.P. Devanand, professor of psychology and neurology at Columbia University and director of the Memory Disorders Center at the New York State Psychiatric Institute.

Dr. Devanand offered the odor-identification test to 150 patients with mild cognitive impairment twice in one year. Sixty-three healthy seniors were tested once. He followed up on the groups’ progress after five years.

His research found that the 10 scents “proved to be the best predictors for Alzheimer’s disease.”

“Narrowing the list of odors can potentially expedite screening and help with early diagnosis,” Dr. Devanand said.

He added that nerve pathways in the brain that perceive and recognize that odors are among the first affected in Alzheimer’s patients.

“This research is very promising. It presents a test that is both low-tech and noninvasive, plus it has some good basic science behind it that makes sense,” said Dr. Gary Small, professor with the Neuropsychiatric Institute at the University of California at Los Angeles and director of its Center on Aging.

“These patients in question can smell things. But they can’t identify what they are smelling. That’s significant,” Dr. Small said, noting that his research measuring the progress of Alzheimer’s in the brain through scans and chemical markers confirms that olfactory processes can be affected in patients with the disease.

“This test involves 10 smells, not 40. It doesn’t take a lot of time. For a physician, that could prove both practical and inexpensive,” he said.

The smell test is one piece of the Alzheimer’s puzzle, and of potential interest to the large population of aging baby boomers.

First identified in 1906, the fatal and degenerative brain disease affects 4.5 million Americans. The number has doubled since 1980 and could quadruple by 2050, according to the Chicago-based Alzheimer’s Association.

The direct and indirect costs of caring for Alzheimer’s patients in the United States are about $100 billion, according to estimates from the National Institute on Aging.

Though there is no cure, the Food and Drug Administration has approved four drugs that can ease some symptoms.

But research for treatments beyond the pharmacy continues.

Based on a study with a dozen physicians and scientists, Dr. Small developed the Memory Prescription Program for people with mild memory problems. The program uses healthy diet, stress-reduction measures, physical conditioning and memory training to improve memory and reduce the possibility of developing Alzheimer’s disease.

In recent years, physicians at Tufts University and the University of California have linked diet with prevention of Alzheimer’s and other age-related memory loss. Their research found that bright-colored fruits and vegetables heavy in antioxidants and foods rich in B vitamins might rejuvenate the brain and memory.

Those edibles include blueberries, cranberries, Concord grapes and dark green, leafy vegetables such as kale.

Still, statistics on Alzheimer’s are alarming.

One in 10 persons older than 65 and almost half of those older than 85 are affected by the disease, which gradually destroys memory judgment and affects behavior. The Alzheimer’s Association has developed a list of warning signs for the disease that separate it from the normal lapses of memory and dispel “myths” associated with the disease.

Its diagnosis and treatment have proved a challenge for physicians, as well as families anxious to determine whether a loved one has Alzheimer’s.

There is no simple, fool-proof test other than an autopsy. After mental and physical assessments, neurological and psychological tests plus laboratory analyses, doctors use a process of elimination to make an Alzheimer’s diagnosis.

“Early diagnosis and treatment can help patients and their families to better plan their lives,” said Dr. Devanand, whose research was funded by the National Institute on Aging.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More

Click to Hide